Alnylam Pharmaceuticals, Inc.

Report date
12/31/2025
Quarter
2025 Q4
Filed
2/12/2026
Shares
2,500
Value ($000)
994
Weight
0.0%
2023 Q2 - 2025 Q4 (11 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).